Cancer pain management-current status
نویسندگان
چکیده
منابع مشابه
Current status of pain management in children.
Many changes have taken place in pediatric pain management since the undertreatment of children's pain was first reported. Notable advances include an increase in understanding pain during development and improvements in the management of acute pain. Although much more about the safe and effective management of pain in children is now known, this knowledge has not been widely or effectively tra...
متن کاملFentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
Breakthrough pain is a newly recognized pain category that was first described by Portenoy and Hagen in 1990. The term describes pain that increases in intensity to "break through" chronic pain that is being controlled by a scheduled opioid regimen. The development of fluctuations in pain intensity is challenging due to their unpredictable nature, rapid onset, and need for rapid treatment inter...
متن کاملCancer pain management in China: current status and practice implications based on the ACHEON survey
PURPOSE Cancer pain can seriously impact the quality of life (QoL) of patients, and optimal management practices are therefore of paramount importance. The ACHEON survey queried physicians and patients from 10 Asian countries/regions to assess current clinical practices in cancer pain management in Asia. This study presents the data obtained for cancer pain management in mainland China, with an...
متن کاملAssociations between pain and current smoking status among cancer patients.
There is growing empirical and clinical interest in purported associations between smoking and the aggravation of cancer symptoms and treatment side effects, such as pain. Both pain and smoking are highly prevalent among persons with cancer, and there is recent evidence to suggest that cancer patients who continue to smoke despite their diagnosis experience greater pain than nonsmokers. Accordi...
متن کاملCancer neuropathic pain: overview of current status and future objectives.
Disclosures: Frederick H. Hausheer: Employment/leadership position: BioNumerik Pharmaceuticals, Inc., KI Pharmaceuticals, Inc.; Intellectual property rights/inventor/patent holder: BioNumerik Pharmaceuticals, Inc.; Ownership interest: BioNumerik Pharmaceuticals, Inc.; Kathleen M. Foley: Consultant/advisory role: NCCN, NCIBCA. The content of this article has been reviewed by independent peer rev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Anaesthesiology Clinical Pharmacology
سال: 2011
ISSN: 0970-9185
DOI: 10.4103/0970-9185.81820